(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 14.8% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23%.
Evolent Health's revenue in 2026 is $2,054,052,000.On average, 16 Wall Street analysts forecast EVH's revenue for 2026 to be $270,520,474,944, with the lowest EVH revenue forecast at $238,714,230,984, and the highest EVH revenue forecast at $295,407,465,832. On average, 14 Wall Street analysts forecast EVH's revenue for 2027 to be $306,232,748,864, with the lowest EVH revenue forecast at $258,244,380,784, and the highest EVH revenue forecast at $338,931,799,672.
In 2028, EVH is forecast to generate $351,431,095,544 in revenue, with the lowest revenue forecast at $324,200,486,680 and the highest revenue forecast at $383,237,339,504.